Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.67 |
| ▸ | CNR1 | P21554 | 11/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.67 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.67 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.67 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.67 |
| ▸ | LDHA | P00338 | 2/20 | 0.67 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.67 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.67 |
| ▸ | MLNR | O43193 | 1/20 | 0.67 |
| ▸ | PDE9A | O76083 | 1/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4863096 | 1.00 | CNR2 (0.67) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL25192923 | 1.00 | CNR2 (0.67) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL29415078 | 1.00 | CNR2 (0.67) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL25661082 | 0.99 | CNR2 (0.68) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL25661069 | 0.99 | CNR2 (0.68) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL23632966 | 0.92 | CNR2 (0.57) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL20192227 | 0.91 | CNR2 (0.69) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL25661075 | 0.91 | CNR2 (0.65) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL23632764 | 0.91 | CNR2 (0.58) | CNR2CNR1OPRM1TRPV1TRPM8 | |
| SCHEMBL24626048 | 0.90 | CNR2 (0.69) | CNR2CNR1OPRM1TRPV1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | claimed |
| US-20060074252-A1 | Synthetic route to dronabinol | SANDOZ INC. | 2006-04-06 | — | — | US | claimed |
| US-20230331690-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | EYBNA TECHNOLOGIES LTD. (IL) | 2023-10-19 | — | — | US | disclosed |
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | ALPHORA RESEARCH INC. (CA) | 2008-12-18 | — | — | US | disclosed |
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | ALPHORA RESEARCH INC. (CA) | 2008-12-18 | — | — | US | disclosed |
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | disclosed |
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | disclosed |
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | disclosed |
| US-20070123719-A1 | Synthesis of cannabinoids | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2007-05-31 | — | — | US | disclosed |
| US-7186850-B2 | Reacting compounds such as Menth-2-ene-1,8-diol with compounds such as Diphenylacetyl chloride to produce 9-tetrahydrocannibinol compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2007-03-06 | — | — | US | disclosed |
| US-20060074252-A1 | Synthetic route to dronabinol | SANDOZ INC. | 2006-04-06 | — | — | US | disclosed |
| US-20060074252-A1 | Synthetic route to dronabinol | SANDOZ INC. | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331690-A1 | THC DERIVATIVES, ORAL DOSAGE FORMS COMPRISING SAME, USES THEREOF FOR TREATING DISEASES AND DISORDERS AND SYNTHESIS THEREOF | CNR2, CNR1, UGT1A10 | CNR2 1/4885CNR1 2/4885OPRM1 62/4885 |
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | CNR1, CNR2, CYP8B1 | CNR2 2/4885CNR1 1/4885OPRM1 5/4885 |
| US-20070123719-A1 | Synthesis of cannabinoids | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885OPRM1 255/4885 |
| US-20060074252-A1 | Synthetic route to dronabinol | CNR1, CNR2, CYP8B1 | CNR2 2/4885CNR1 1/4885OPRM1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.